Hospital Geral de Santo António, part of the Centro Hospitalar do Porto, is a central and teaching hospital in Porto, Portugal. It focuses on providing healthcare that improves patient and population health, particularly in areas of high specialization. The hospital is deeply integrated with other health institutions and places a strong emphasis on both undergraduate and postgraduate education. It also encourages research with the aim of advancing health science and technology​​.

The hospital operates under the legal entity Hospital Geral de Santo António E.P.E and is involved in various activities including public contracts and has financial details available such as sales volume, costs, profits, and employee information​​.

Hospital Geral de Santo António, part of the Centro Hospitalar Universitário do Porto, offers a wide range of specialized medical services. The hospital is renowned for its comprehensive care in areas such as neurosciences, immunology, ophthalmology, oncology, hematology, and various systemic diseases including infectious, kidney, and amyloidosis diseases. Additionally, it has significant capabilities in human genetics, rare metabolic diseases, and organ transplantation. The hospital also specializes in hepatobiliary and colon surgery, intensive care, and anesthesiology.

Moreover, the hospital is actively involved in several European and national networks, focusing on a variety of medical fields like metabolic diseases, rare cancers, transplantation, immunodeficiencies, and neuromuscular diseases, among others. It also plays a crucial role in national and international clinical trials, contributing significantly to the development of new treatments and medicines​​.

The Hospital Geral de Santo António, part of the Centro Hospitalar Universitário do Porto, is highly regarded for its extensive range of medical services and specialties. This institution is a central hub for patient care, medical education, and research, particularly noted for its involvement in high-differentiation activities and collaboration with other health institutions. It places a strong emphasis on both undergraduate and postgraduate medical education and actively promotes research to advance health science and technology​​.

Additionally, the hospital is involved in several European Reference Networks (ERNs) dealing with rare diseases, which highlights its capacity for specialized medical treatment and research in areas like rare hematological, kidney, immunodeficiencies, neuromuscular, and connective tissue diseases. The hospital also focuses on various adult oncology specialties, including esophageal, testicular, bone and soft tissue, rectal, and hepatobiliary-pancreatic cancers. Furthermore, it offers significant services in transplantation, including kidney, pancreas, and liver transplantation​​.

This broad spectrum of specialized services underlines the hospital's role as a key player in both national and international healthcare networks, contributing significantly to clinical trials and research partnerships across Europe, particularly in areas like active and healthy aging and the acceleration of clinical trials for COVID-19 vaccines through the VACCELERATE project​.

The strategic direction and purpose of the Hospital Geral de Santo António, part of the Centro Hospitalar Universitário do Porto (CHUP), are focused on providing highly differentiated healthcare services, supporting and coordinating with other health institutions to improve patient health and public health outcomes. The hospital emphasizes the importance of education, offering pre-graduate and postgraduate training, and is actively engaged in research to advance health science and technology​​.

The hospital is also involved in various European Networks (ERNs), coordinating on issues like metabolic diseases, transplantation, respiratory diseases, rare cancers, hematological diseases, and more. This participation underlines its commitment to addressing complex and rare diseases through collaborative networks across Europe​​.

Furthermore, CHUP is a part of several research projects and clinical trials, including initiatives like VACCELERATE for COVID-19 vaccine trials and CHAIMELEON for AI-driven cancer management. These projects highlight the hospital's role in international research and its strategy to foster innovation and excellence in healthcare​​.

The Hospital Geral de Santo António has consistently been recognized for its performance, indicating a strategic commitment to excellence and research, with significant investment in these areas to maintain its status as a leading hospital in Portugal​ (Portal de notícias do Porto. Ponto.)​.

The Hospital Geral de Santo António, part of the Centro Hospitalar Universitário do Porto, has earned notable recognition for its achievements in various medical fields. Notably, the hospital received the AICIB Award 2021 from the Agency for Clinical Research and Biomedical Innovation for a project focused on clinical trials in a pediatric environment​​. Additionally, the hospital is accredited by Casper Healthcare Knowledge Systems (CHKS), highlighting its commitment to maintaining high standards in healthcare services​​.

These accolades reflect the hospital's dedication to excellence in medical research, clinical services, and patient care.